Treatment of stimulant use disorder: A systematic review of reviews - PubMed (original) (raw)

Treatment of stimulant use disorder: A systematic review of reviews

Claire Ronsley et al. PLoS One. 2020.

Abstract

Aims: Stimulant use disorder contributes to a substantial worldwide burden of disease, although evidence-based treatment options are limited. This systematic review of reviews aims to: (i) synthesize the available evidence on both psychosocial and pharmacological interventions for the treatment of stimulant use disorder; (ii) identify the most effective therapies to guide clinical practice, and (iii) highlight gaps for future study.

Methods: A systematic database search was conducted to identify systematic reviews and meta-analyses. Eligible studies were those that followed standard systematic review methodology and assessed randomized controlled trials focused on the efficacy of interventions for stimulant use disorder. Articles were critically appraised using an assessment tool adapted from Palmeteer et al. and categorized for quality as 'core' or 'supplementary' reviews. Evidence from the included reviews were further synthesized according to pharmacological or non-pharmacological management themes.

Results: Of 476 identified records, 29 systematic reviews examining eleven intervention modalities were included. The interventions identified include: contingency management, cognitive behavioural therapy, acupuncture, antidepressants, dopamine agonists, antipsychotics, anticonvulsants, disulfiram, opioid agonists, N-Acetylcysteine, and psychostimulants. There was sufficient evidence to support the efficacy of contingency management programs for treatment of stimulant use disorder. Psychostimulants, n-acetylcysteine, opioid agonist therapy, disulfiram and antidepressant pharmacological interventions were found to have insufficient evidence to support or discount their use. Results of this review do not support the use of all other treatment options.

Conclusions: The results of this review supports the use of contingency management interventions for the treatment of stimulant use disorder. Although evidence to date is insufficient to support the clinical use of psychostimulants, our results demonstrate potential for future research in this area. Given the urgent need for effective pharmacological treatments for stimulant use disorder, high-quality primary research focused on the role of psychostimulant medications for the treatment of stimulant use disorder is needed.

PubMed Disclaimer

Conflict of interest statement

No authors have competing interests.

Figures

Fig 1

Fig 1. Flow diagram of the selection and review process for review articles.

Similar articles

Cited by

References

    1. Uhlmann S, DeBeck K, Simo A, Kerr T, Montaner JS, Wood E. Health and social harms associated with crystal methamphetamine use among street-involved youth in a Canadian setting. Am J Addict. 2014;23(4):393–8. 10.1111/j.1521-0391.2014.12123.x - DOI - PMC - PubMed
    1. Cunningham EB, Jacka B, DeBeck K, Applegate TL, Harrigan PR, Krajden M, et al. Methamphetamine injecting is associated with phylogenetic clustering of hepatitis C virus infection among street-involved youth in Vancouver, Canada. Drug Alcohol Depend. 2015;152:272–6. 10.1016/j.drugalcdep.2015.04.005 - DOI - PMC - PubMed
    1. Operskalski EA, Mack WJ, Strickler HD, French AL, Augenbraun M, Tien PC, et al. Factors associated with hepatitis C viremia in a large cohort of HIV-infected and -uninfected women. J Clin Virol. 2008;41(4):255–63. 10.1016/j.jcv.2007.08.021 - DOI - PMC - PubMed
    1. Darke S, Torok M, Kaye S, Ross J, McKetin R. Comparative rates of violent crime among regular methamphetamine and opioid users: offending and victimization. Addiction. 2010;105(5):916–9. 10.1111/j.1360-0443.2009.02872.x - DOI - PubMed
    1. Saddichha S, Werker GR, Schuetz C, Krausz MR. Stimulants and Cannabis Use Among a Marginalized Population in British Columbia, Canada: Role of Trauma and Incarceration. Int J Offender Ther Comp Criminol. 2015;59(13):1487–98. 10.1177/0306624X14541661 - DOI - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources